ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase 1 Safety Study of the Intravenous Administration of Thymosin Beta in Healthy Volunteers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00743769
Recruitment Status : Withdrawn (Study never initiated due to contract manufacturing issues)
First Posted : August 29, 2008
Last Update Posted : April 17, 2017
Sponsor:
Information provided by (Responsible Party):
RegeneRx Biopharmaceuticals, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Actual Primary Completion Date : January 1, 2017
  Actual Study Completion Date : January 1, 2017